Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,152 | 278 | 97.5% |
| Education | $159.82 | 3 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $1,153 | 47 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $892.56 | 63 | $0 (2022) |
| ABBVIE INC. | $875.90 | 32 | $0 (2024) |
| Gilead Sciences, Inc. | $816.76 | 34 | $0 (2023) |
| Novo Nordisk Inc | $574.10 | 26 | $0 (2023) |
| PFIZER INC. | $435.38 | 22 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $323.52 | 14 | $0 (2023) |
| Merck Sharp & Dohme LLC | $319.28 | 16 | $0 (2023) |
| Amgen Inc. | $309.14 | 5 | $0 (2023) |
| Janssen Products, LP | $211.45 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32.57 | 1 | ABBVIE INC. ($32.57) |
| 2023 | $2,488 | 97 | ABBVIE INC. ($764.43) |
| 2022 | $1,403 | 68 | ViiV Healthcare Company ($521.79) |
| 2021 | $2,388 | 115 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($528.18) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.36 | General |
| 09/07/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Respiratory | ||||||
| 09/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: PSYCHIATRY | ||||||
| 08/30/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/22/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Respiratory | ||||||
| 08/18/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.47 | General |
| 08/18/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: HIV | ||||||
| 08/01/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Diabetes | ||||||
| 07/25/2023 | Merck Sharp & Dohme LLC | PNEUMOVAX 23 (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: VACCINE | ||||||
| 07/24/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/24/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Respiratory | ||||||
| 07/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2023 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: INFECTIOUS DISEASE | ||||||
About Monika Maclean, APRN
Monika Maclean, APRN is a Adult Health healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2017. The National Provider Identifier (NPI) number assigned to this provider is 1326565342.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Monika Maclean, APRN has received a total of $6,312 in payments from pharmaceutical and medical device companies, with $32.57 received in 2024. These payments were reported across 281 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($6,152).
Practice Information
- Specialty Adult Health
- Other Specialties Gerontology, Gerontology
- Location New York, NY
- Active Since 08/30/2017
- Last Updated 11/13/2023
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1326565342
Products in Payments
- XIFAXAN (Drug) $892.56
- DOVATO (Drug) $741.19
- QULIPTA (Drug) $485.96
- Otezla (Drug) $309.14
- CABENUVA (Biological) $259.11
- COLOGUARD DNA CAPTURE REAGENTS (Device) $256.16
- FARXIGA (Drug) $228.70
- VRAYLAR (Drug) $222.50
- SYMTUZA (Drug) $216.43
- Rybelsus (Drug) $205.88
- Epclusa (Drug) $168.59
- Ozempic (Drug) $161.94
- PIFELTRO (Drug) $158.51
- APRETUDE (Biological) $153.16
- UBRELVY (Drug) $145.69
- RYBELSUS (Drug) $139.92
- Biktarvy (Drug) $124.92
- BELSOMRA (Drug) $112.76
- BREZTRI (Drug) $94.82
- JARDIANCE (Drug) $90.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in New York
Ms. Donna Catamero, Np, NP
Adult Health — Payments: $173,379
Mrs. Juliet Escalon, Anp, ANP
Adult Health — Payments: $45,931
Alyson Harty, Np, NP
Adult Health — Payments: $41,841
Teshmanie Rampersaud, Np, NP
Adult Health — Payments: $22,782
Mrs. Monica Richey, Np, NP
Adult Health — Payments: $17,240
Damaris Carriero, Np, NP
Adult Health — Payments: $15,518